FOI 26-1882 – Devin Case, US Gender Dysphoria Report

Written by Claude Haiku 4.5 from the extracted text on 27 Feb 2026. It can miss or misread redacted and scanned pages. Check the source before relying on it.

The Department of Health and Aged Care tasked the National Health and Medical Research Council (NHMRC) on 31 January 2025 to develop new national clinical practice guidelines for trans and gender diverse children and adolescents in Australia, with initial advice on puberty suppressing medicines expected by mid-2026. The document notes that approximately 1% of Australians aged 16+ (178,900 people) identify as trans and gender diverse, though not all pursue medical gender affirmation. Current care is led by states and territories through multidisciplinary specialist services, with treatment decisions shared between clinicians, young people, and families; disputed cases proceed to family court. There is no singular Medicare Benefits Schedule item covering all gender affirmation consultations and procedures; clinicians use existing MBS items based on individual clinical judgment. The disclosure acknowledges this is a complex, evolving clinical area where longer-term evidence to inform treatment protocols remains